Buscar
Mostrando documentos 31-33 de 33
Race for a vaccine
POTTERING around her kitchen on the
morning of 31 December, Kate Broderick
scrolled through the headlines while
she waited for her tea to brew. One story caught
her eye: a mysterious outbreak of severe
pneumonia in ...
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Background A vaccine to protect against COVID-19 is urgently needed. We aimed to assess the safety, tolerability, and
immunogenicity of a recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine expressing the ...
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARSCoV-2
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The development of a vaccine is urgently needed for the
prevention ...